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Abstract 
A method is described for the analysis of/3-agonists in urine of cattle. The method uses solid-phase xtraction 
(SPE), followed by analysis of the resulting extract by flow injection thermospray tandem mass spectrometry 
(qSP-MS-MS). Sample preparation is performed using a mixed-bed SPE procedure using a sorbent having both 
hydrophobic and ionic properties. MS-MS analysis following thermospray ionization, is performed in single- 
reaction monitoring parent mode. In that way isotope dilution can be used for quantitation of clenbuterol. Data are 
presented on precision and accuracy for clenbuterol and related compounds. Furthermore, data acquisition was 
performed in full-scan neutral loss mode to indicate the suitability of flow injection analysis (FIA)-TSP-MS-MS for 
exploratory analysis. Detection of /~-agonists in this mode is based on the presence of the N-tert.-butyl-~- 
ethanolamino moiety and, in that respect, detection of known as well as unknown compounds having this moiety 
will take place. This feature is exemplified by the analysis of samples containing several compounds. 
1. Introduction 
In the EC the use of /3-agonists as growth 
promoting agents in the fattening of animals for 
human consumption is banned. Nevertheless 
these compounds are frequently found in the 
urine of cattle and analysis for the purpose of 
regulatory control is carried out in most, if not 
all, countries. Besides regulatory control, there 
is a growing interest in methods suitable for 
"real-time" analysis to perform process control. 
Within the FLAIR (Food-Linked Agro-Indus- 
trial Research) Concerted Action nr. 8 this 
subject was studied extensively and part of the 
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presented work was carried out within the flame- 
work of this EC project. 
Furthermore, an additional analytical problem 
is the use of slightly modified compounds for 
growth promotion. These compounds are usually 
not detected whenever a target-compound ap- 
proach is applied. 
For regulatory control, the analysis is usually 
carried out using GC-MS in the multiple ion 
detection (MID) mode [1,2]. Although a very 
effective technique, it has three major draw- 
backs: the compounds are targeted, so related 
compounds will not be detected, derivatization is 
usually necessary and this may impart unwanted 
selectivity and variability and, furthermore, the 
procedure typically takes two days to carry out. 
Whenever the results of analysis should be 
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available on a short term, as for "real-time" 
analysis, GC-MS methods generally are not very 
suitable. In that case application of LC-MS-MS 
techniques may offer better performance. 
We present here a flow injection (FIA)-TSP- 
MS-MS method that may be used in either of 
two ways: (a) a method for semi-quantitative 
target-compound analysis that is suitable for very 
rapid analysis of residues of/3-agonists and (b) a 
method for rapid qualitative group-specific anal- 
ysis of nanogram amounts of known as well as 
unknown/3-agonists. 
2. Experimental 
2.1. Materials and instrumentation 
All reagents used were of analytical grade. 
The absence of /3-agonists in  the blank urine 
used for spiking experiments was demonstrated 
using a method based on GC-MS with a limit of 
detection of 0.2 ng/ml [1]. 
Clenbuterol-d6, the analogue of clenbuterol 
where six protons at the tert.-butyl moiety are 
substituted with six deuterons, was used as an 
internal standard, allowing quantitation by iso- 
tope dilution. 
Sample preparation was performed using 
XtrackT columns XRDAF515 (World Wide 
Monitoring, Bristol, PA, USA) containing 500 
mg of a sorbent having ionic and hydrophobic 
properties. The clean-up procedure was adapted 
from the procedure published by Montrade et al. 
[3]. In brief, samples are hydrolyzed using 
glucuronidase/arylsulfatase from Helix pomatia 
at pH 4.8, using acetate buffer for pH adjust- 
ment. Following hydrolysis, the pH is adjusted 
to 6.0 using 0.1 M phosphate buffer and the 
extract is applied to a column conditioned with 3 
ml each of methanol, water and 0.1 M phosphate 
buffer. The column is washed with 0.1 M phos- 
phate buffer and the analytes are eluted with 
methanol containing 3% concentrated ammo- 
nium hydroxide. 
The analysis is carried out using a Finnigan 
MAT TSQ70 (San Jose, CA, USA) mass spec- 
trometer equipped with a thermospray II inter- 
face. The interface is operated at 200°C block 
temperature and 90°C vaporizer temperature. 
The repeller was at 80 V, no discharge ionization 
was used. Argon was used as collision gas at a 
pressure reading of 1.2 mTorr and a collision 
offset of -13 eV was applied. The carrier eluent 
consisted of 30% methanol in water with an 
overall concentration of 0.05 M ammonium 
acetate. The solvent was pumped at a flow-rate 
of 1.0 ml/min by a Gilson 305 pump (Villiers-le- 
Bel, France) equipped with an additional pulse 
damper. Aliquots of 50/xl were injected directly 
into the carrier eluent by means of a Gilson 
231-401 autosampler. 
2.2. Data acquisition 
To perform semi-quantitative analysis, a pro- 
cedure for single reaction monitoring (SRM) in 
parent mode was used, monitoring the loss of 
water (M r 18) and methylpropene (M r 56) from 
the molecular ions. For cimaterol and 
clenbuterol-d 6 corresponding losses were moni- 
tored (Table 1). By applying parent mode data 
acquisition, the data system will record the 
masses of the precursor ions rather than the 
masses of the product ions. In this way the use of 
clenbuterol-d 6 as an internal standard becomes 
possible regardless of the fact that the mass of 
the product ion monitored is the same as for 
unlabelled clenbuterol. 
Urine samples were spiked with five/3-agonists 
(cimaterol, clenbuterol, terbutaline, mabuterol 
and salbutamol) at 1, 2 and 5 ng/ml, respective- 
ly. Aliquots of 5 ml of urine each from each 
spiking level were analyzed in triplicate. Follow- 
ing clean-up, to each extract 15 ng of 
clenbuterol-d6, corresponding to 3 ng/ml in the 
urine, was added as an internal standard. The 
extracts were evaporated to dryness and redis- 
solved in 0.50 ml of carrier eluent. Subsequently 
the extracts were analyzed using FIA-TSP-MS- 
MS in SRM parent mode. Aliquots of 50 p.l, 
corresponding to 0.5 ml of urine, were injected 
in duplicate. 
To perform group-specific qualitative analysis, 
data acquisition is performed in full-scan neutral 
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Table 1 
Molecular structure and SRM data for the investigated analytes 
69 
Name 
RI 
HOCH-- CH 2-NH- R1 
R2+R4 
R 3 
R2 R3 R4 
SRM 
Clenbuterol C(CH3)3 
(CLEN) 
Clenbuterol-d, C(C2H3)2CH3 
(CLEN-d6) 
Mabuterol C(CH3)  3 
(NAB) 
Terbutaline C(CH3)3 
(TER) 
Salbutamol C(CH3)3 
(SAL) 
Cimaterol CH(CH3) 2 
(CIM) 
Cl NH_, CI 277--~ 203 
C1 NH 2 CI 283 ~ 203 
C1 NH, CF 3 311 ~ 237 
OH H OH 226--~ 152 
CH,OH OH H 240---~ 166 
CN NH 2 H 220--> 160 
loss mode. The scanning range of the first 
quadrupole is from 200 to 370 amu at one scan 
per second. Consequently the scan range of the 
second quadrupole is from 126 to 296 ainu. 
3. Results and discussion 
3.1. Semi-quant i tat ive determinat ion 
Fig. 1 shows a typical result for the analysis of 
urine samples spiked at 1 ng/ml. Table 2 pre- 
sents the corresponding quantitative data of the 
three spiking levels tested. From Fig. 1 it is clear 
that detection of all analytes except salbutamol is 
readily performed at 1 ng/ml level with sufficient 
signal-to-noise ratio. For salbutamol, signal-to- 
noise ratio is low and, although this compound is 
detected, the limit of detection (LOD)  is equal 
to 1 ng/ml. For the other compounds, based on 
signal-to-noise ratio, a LOD of at least 0.5 ng/ml 
in the urine is achievable. Reagent blanks do not 
indicate the presence of any of the analytes. 
Analysis of the blank urine extract, however, 
seems to indicate the presence of cimaterol and 
clenbuterol. For cimaterol this is most likely 
caused by interfering compounds, because all 
urine blanks analyzed during this study show a 
comparable blank offset. These interferences 
were not characterized any further. Consequent- 
ly, for cimaterol the clean-up has to be improved 
or, alternatively, chromatographic separation of 
the analyte and the interference may be applied. 
For clenbuterol, other urine blanks did not show 
an offset, so for this compound it may have been 
incidental contamination. However, especially 
for clenbuterol the signal is rather small and 
quantitation yields a blank offset of approxi- 
mately 0.3 ng/ml. 
Quantitation is carried out by using 
clenbuterol-d 6 as an internal standard. For clen- 
buterol the quantitative results are therefore 
acceptable, especially when taking into account 
that clenbuterol-d6 is only added after clean-up 
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Fig. 1. SRM profiles for the FIA-TSP-MS-MS analysis of urine samples spiked at 1 ng/ml with five /3-agonists. 
so recovery losses are not corrected. For the 
other compounds, quantitative results should be 
improved. Repeatability is again acceptable for 
clenbuterol and perhaps for mabuterol and ter- 
butaline, but also here improvements have to be 
made. However, as the use of these compounds 
in the fattening of animals for human consump- 
tion is banned within the EC, indication of the 
presence itself is more important than accurate 
quantitative results. Improvement of quantita- 
tion may be achieved by using isotope-labelled 
standards added before clean-up. Particularly for 
salbutamol the use of salbutamol-d 6 as an inter- 
nal standard could improve quantitation. The 
results of analysis justify the statement hat the 
presented method yields at least semi-quantita- 
tive information, except for salbutamol. 
Together with the clean-up, not including 
hydrolysis, the entire procedure, including cali- 
bration, can be performed within two hours for a 
Table 2 
Results for the analysis of clenbuterol (CLEN), salbutamol (SAL), cimaterol (CIM), terbutaline (TER) and mabuterol (MAB) in 
spiked urine samples purified on XtrackT SPE columns 
Spike level 
(ng/ml) 
CLEN SAL CIM TER MAB 
Mean C.V. Mean C.V. Mean C.V. Mean C.V. Mean C.V. 
(ng/ml) (%) (ng/ml) (%) (ng/ml) (%) (ng/ml) (%) (ng/ml) (%) 
1.0 1.1 15 1.6 28 1.5 25 1.0 21 0.7 21 
2.0 2.4 18 4.3 31 2.7 19 1.9 9 1.5 18 
5.0 4.4 12 12.2 19 5.9 7 5.6 14 2.9 8 
J .A. van Rhijn et al. / J. Chromatogr. A 712 (1995) 67-73 71 
set of 20 samples. In that respect he method is 
far more rapid than any GC-MS method now 
available. 
3.2. Qualitative determination 
Tandem mass spectrometry may also be used 
for exploratory analysis to detect the possible 
presence of unknown compounds. Using neutral 
loss scanning, the loss of 74 amu can be moni- 
tored, corresponding to the loss of water fol- 
lowed by the loss of methylpropene from the 
molecular ion. It is assumed that for all N-tert.- 
butyl substituted /3-ethanolamines, this frag- 
mentation will occur when using alike ex- 
perimental parameters. For all known com- 
pounds this has been confirmed in our labora- 
tory. 
Fig. 2 shows the analysis of a 50-/~i aliquot, 
corresponding to 0.5 ml of urine, of a urine 
extract spiked prior to clean-up, at 3 ng/ml, with 
several /3-agonists. The presence of the peak at 
4.4 rain indicates the presence of one or more 
compounds that comply with the scanning re- 
quirement: the loss of 74 amu. 
The inset in Fig. 2 shows the CID spectrum 
averaged over the peak at 4.4 min. This spec- 
trum indicates the presence of salbutamol [M + 
H] + at m/z 240 and [M+ H-H20]  + at m/z 
222, terbutaline [M+H]  + at m/z 226, clen- 
buterol [M + H] + at m/z 277/279 and mabuterol 
[M+H]  + at m/z 311/313. It is obvious that 
these compounds are readily detected at this 
concentration level. The presence of two frag- 
ment ions for salbutamol may be the reason for 
the low sensitivity in the semi-quantitative analy- 
sis, because there the loss of 74 ainu from only 
one ion (m/z 240) is monitored. 
To exemplify the detection of possible un- 
knowns, a rather artificial experiment was car- 
ried out. Recently the abuse of the brominated 
analog of clenbuterol was discovered [4]. At that 
time, in our laboratory, GC-MS was used for 
the analysis. One of these samples was analyzed 
using the presented method. Experimental con- 
ditions were the same as in Fig. 2. Again an 
aliquot equivalent to 0.5 ml of urine was injected 
while scanning the mass spectrometer for the loss 
of 74 ainu. Fig. 3 indicates the presence of 
compound(s) losing 74 amu, and the averaged 
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Fig. 2. In ject ion of an extract of a urine sample spiked at 3 ng/ml ,  indicat ing the s imul taneous detect ion of all N-tert.-butyl 
subst i tuted compounds  present.  The mass spectrometer  was operated in full-scan neutral  loss (74 u) mode.  
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Fig. 3. Injection of an extract of a urine sample xemplifying the detection of a possible unknown compound. The CID spectrum 
reveals the presence of bromobuterol. The amount was estimated at 0.7 ng/ml in the urine. 
CID spectrum reveals the presence of a com- 
pound containing two bromine atoms with a 
mono-isotopic molecular mass of 364, [M+ 
H] + = 365. This compound was previously iden- 
tified as bromobuterol,  the brominated analog of 
clenbuterol. Using GC-MS,  the amount was 
estimated at 0.7 ng/ml assuming a response per 
mass unit equal to clenbuterol. 
From the above examples, the possibilities of 
tandem MS for group-specific detection, in this 
case specific for N-tert.-butyl substituted /3- 
ethanolamines, are apparent even for low con- 
centration levels like 1 ng/ml, although this 
strongly depends on the compound. It should be 
emphasized, however, that the loss of 74 amu 
may not be an exclusive feature of N-tert.-butyl 
substituted /3-ethanolamines alone, so interfer- 
ence may occur. Only the analysis of a large 
number of samples from as diverse origin as 
possible will indicate whether or not the specifici- 
ty is sufficient. Currently this item is under 
investigation. 
4. Conclusion 
The presented method may be used for rapid 
analysis of several/3-agonists in urine in a semi- 
quantitative fashion at sub-ng/ml evels. Analy- 
sis is rapid but specificity should be studied more 
extensively. Operating the mass spectrometer in
full-scan neutral loss mode, the possibilities of 
tandem mass spectrometry for group-specific 
detection of structure-related compounds are 
indicated. Detection of an unknown as well as 
known compounds at ng/ml levels is demon- 
strated. 
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